Status:
COMPLETED
The Effects of Smoking on miRNA-223 Before-After Non-Surgical Periodontal Therapy
Lead Sponsor:
Biruni University
Conditions:
Periodontal Therapy
miRNA-223
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Periodontal diseases are one of the most common inflammatory diseases. Periodontal disease results from a complex interplay between the subgingival biofilm and the host immune-inflammatory events that...
Eligibility Criteria
Inclusion
- Periodontal healthy group
- Stage III Grade B-C Periodontitis Group
- To meet the above-mentioned periodontal health and disease criteria
Exclusion
- Periodontal tissues, periodontal disease course, periodontal application training and to have,
- Chronic alcohol use,
- Oral contraceptive use, pregnancy, pregnant,
- Last 6 system or anti-inflammatory drug use,
- To have developed periodontal in the last 6 months.
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05372965
Start Date
May 5 2022
End Date
December 12 2023
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biruni Üniversitesi
Istanbul, İstanbul, Zeytinburnu, Turkey (Türkiye), 34025